DekaBank Deutsche Girozentrale Share Price

Certificat

DE000DK0SQC6

Market Closed - Boerse Frankfurt Warrants 08:30:34 31/05/2024 pm IST
1,097 EUR +0.92% Intraday chart for DekaBank Deutsche Girozentrale
1 month+8.40%
3 months+22.23%
Date Price Change
31/24/31 1,097 +0.92%
30/24/30 1,087 +0.59%
29/24/29 1,081 -0.96%
28/24/28 1,091 -0.01%
27/24/27 1,092 +2.50%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 08:30 pm IST

More quotes

Static data

Product typeCertificati Altri
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
Issuer Deka
WKN DK0SQC
ISINDE000DK0SQC6
Date issued 18/02/2019
Strike 47.26
Maturity 10/04/2025 (313 Days)
Parity 0.05 : 1
Emission price 1,000
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1,148
Lowest since issue 561.5
Spread 10
Spread %0.90%

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
29.28 EUR
Average target price
36.72 EUR
Spread / Average Target
+25.43%
Consensus